Regional Institute of Ophthalmology, Thiruvananthapuram, Kerala, India
Address for correspondence: Dr. Anooja R Babu, Regional Institute of Ophthalmology, Thiruvananthapuram, Kerala, India. E-mail: [email protected]
Received November 28, 2022
Received in revised form November 28, 2022
Accepted November 28, 2022
This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
The case report “Off-center Presentation of Ocular Myasthenia” by Dr. Mary A. Stephen has highlighted the case report of a 70-year-old diabetic male who presented with diplopia.[1] The article brilliantly described a presentation of ocular myasthenia and highlighted the need for a high degree of suspicion for timely diagnosis of ocular Myasthenia Gravis. In this case, the initial diagnosis of diabetic mononeuropathy changed to ocular myasthenia when the initial presentation of unilateral ptosis gradually evolved to bilateral ptosis. Early detection of myasthenia is important as the management of diabetic mononeuropathy is entirely different from that of myasthenia, which the author achieved by meticulous examination of the patient and by timely clinical suspicion.
From an academic point of view, the few points that I would like to contribute include:
- Thoracic imaging like MRI or CT scan could have been done to detect thymoma, as it is present in 15% of cases.[23]
- Testing for striational antibodies can help determine the severity as it is a marker of severe Myasthenia Gravis (MG). Nearly all patients with MG and thymoma and half of the late-onset MG subgroup demonstrate the presence of striational antibody.[4]
- In seropositive cases, the titers of AchR (Acetylcholine Receptor) antibody are found to be significantly higher in patients who progressed to generalized disease than those whom it remained as ocular.[5]
Financial support and sponsorship
Nil.
Conflicts of interest
There are no conflicts of interest.
REFERENCES
1. Stephen MA, Jayasri P, Harigaravelu PJ. Off-center presentation of ocular myasthenia Kerala J Ophthalmol. 2022;34:164–6
2. O'Hare M, Doughty C. Update on ocular myasthenia gravis Semin Neurol. 2019;39:749–60
3. Fortin E, Cestari DM, Weinberg DH. Ocular myasthenia gravis: An update on diagnosis and treatment Curr Opin Ophthalmol. 2018;29:477–84
4. Nair AG, Patil-Chhablani P, Venkatramani DV, Gandhi RA. Ocular myasthenia gravis: A review Indian J Ophthalmol. 2014;62:985–91
5. Kusner LL, Puwanant A, Kaminski HJ. Ocular myasthenia: Diagnosis, treatment, and pathogenesis Neurologist. 2006;12:231–9
